Author

Samar Salem

Hebrew University of Jerusalem

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:multiome· 1

Frequent Co-Authors

Adina R. HeinbergiD· 1 shared Anurag V PrabhuiD· 1 shared Carla Azar-Koussa· 1 shared Efraim RahamimiD· 1 shared Eran ZimraniD· 1 shared Erez Y. LevanoniD· 1 shared Marina Sakran· 1 shared Meital Ben-David-NaimiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Adina R. HeinbergORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting the 3' splice site by a decoy oligonucleotide attenuates U2AF1 splicing activity and inhibits leukemia

Carla Azar-Koussa, Marina Sakran, Efraim Rahamim, Anurag V Prabhu, Samar Salem, Adina R. Heinberg, Zahava Siegfried, Meital Ben-David-Naim, Eran Zimran, Erez Y. Levanon, Zvi Granot, Rotem Karni

This paper develops an RNA decoy strategy to inhibit splicing factor activity in leukemia, showing it reduces tumor burden in vivo regardless of spliceosomal mutations.

bioRxiv · Jul 7, 2026 · PreprintMolecular Biology